tiprankstipranks
Trending News
More News >
Crispr Therapeutics (DE:1CG)
:1CG
Germany Market

Crispr Therapeutics AG (1CG) Technical Analysis

Compare
12 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Crispr Therapeutics’s (1CG) Moving Averages Convergence Divergence (MACD) indicator is 0.95, suggesting Crispr Therapeutics is a Sell.
Crispr Therapeutics’s (1CG) 20-Day exponential moving average is 36.33, while Crispr Therapeutics’s (1CG) share price is €38.6, making it a Buy.
Crispr Therapeutics’s (1CG) 50-Day exponential moving average is 36.33, while Crispr Therapeutics’s (1CG) share price is €38.6, making it a Buy.

Crispr Therapeutics AG (1CG) Pivot Points

Jun 24, 2025, 12:03 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
38.00
38.40
38.60
39.00
39.20
39.60
39.80
Fibonacci
38.40
38.63
38.77
39.00
39.23
39.37
39.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (1CG) Moving Averages

Jun 24, 2025, 12:03 PM
Period
Simple
Exponential
MA5
38.16Buy
38.18Buy
MA10
37.50Buy
37.35Buy
MA20
35.49Buy
36.33Buy
MA50
36.03Buy
36.33Buy
MA100
38.01Buy
37.34Buy
MA200
39.01Sell
38.38Buy
Crispr Therapeutics’s (1CG) 10-Day exponential moving average is 37.35, while Crispr Therapeutics’s (1CG) share price is €38.6, making it a Buy.
Crispr Therapeutics’s (1CG) 100-Day exponential moving average is 37.34, while Crispr Therapeutics’s (1CG) share price is €38.6, making it a Buy.
Crispr Therapeutics’s (1CG) stock price is €38.6 and Crispr Therapeutics’s (1CG) 50-day simple moving average is 36.03, creating a Buy signal.
Crispr Therapeutics’s (1CG) stock price is €38.6 and Crispr Therapeutics’s (1CG) 100-day simple moving average is 38.01, creating a Buy signal.
Crispr Therapeutics’s (1CG) stock price is €38.6 and Crispr Therapeutics’s (1CG) 200-day simple moving average is 39.01, creating a Sell signal.

Crispr Therapeutics AG (1CG) Technical Indicators

Jun 24, 2025, 12:03 PM
Name
Value
Implied Action
RSI (14)
60.56
Neutral
STOCH (9,6)
82.09
Sell
STOCHRSI (14)
87.08
Sell
MACD (12,26)
0.95
Sell
ADX (14)
-
Williams %R
-17.95
Sell
CCI (14)
112.95
Sell
ATR (14)
1.60
-
Ultimate Oscillator
52.13
Neutral
ROC
15.57
Buy
Crispr Therapeutics’s (1CG) Relative Strength Index (RSI) is 60.56, creating a Neutral signal.
Crispr Therapeutics’s (1CG) Commodity Channel Index (CCI) is 112.95, creating a Sell signal.
Crispr Therapeutics’s (1CG) Price Rate of Change (ROC) is 15.57, creating a Buy signal.

FAQ

Is 1CG a Buy, Hold, or Sell?
Based on 1CG’s technical indicators, 1CG is a Buy.
    What is 1CG’s RSI (14)?
    1CG’s RSI (14) is 60.56, which suggests 1CG is a Neutral.
      What is 1CG’s MACD?
      1CG’s MACD is 0.95, which suggests 1CG is a Sell.
        What is 1CG’s 5-day moving average?
        1CG’s 5-day moving average is 38.16, which suggests 1CG is a Buy.
          What is 1CG’s 20-day moving average?
          1CG 20-day moving average is 35.49, which suggests 1CG is a Buy.
            What is 1CG’s 50-day moving average?
            1CG’s 50-day moving average is 36.03, which suggests 1CG is a Buy.
              What is 1CG’s 200-day moving average?
              1CG’s 200-day moving average is 39.01, which suggests 1CG is a Sell.
                What is 1CG’s Williams % R (14)?
                1CG’s Williams % R (14) is -17.95, which suggests 1CG is a Sell.
                  What is 1CG’s CCI (14)?
                  1CG’s CCI (14) is 112.95, which suggests 1CG is a Sell.
                    What is the share price of Crispr Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis